Nifty
:
24154.90
Sensex
:
77235.46
-132.75 (-0.55%)
-492.70 (-0.63%)
Nifty
Sensex
:
:
24154.90
77235.46
-132.75 (-0.55%)
-492.70 (-0.63%)

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
50/99

BSE: 533543 | NSE: BROOKS

NSE BSE
58.94
18-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  58.8
  •  61
  •  58.5
  •  60.66
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  22575
  •  1333169.61
  •  163.9
  •  36.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 174.77
  • 13.23
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 174.50
  • N/A
  • 1.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.62%
  • 3.29%
  • 30.73%
  • FII
  • DII
  • Others
  • 0%
  • 9.90%
  • 3.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.07
  • -1.22
  • 2.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 30.30
  • 18.12

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.26
  • 53.98
  • 55.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.45
  • 3.45
  • 3.62

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.36
  • 26.36
  • 45.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
22.96
25.51
-10.00%
20.21
23.32
-13.34%
16.57
20.52
-19.25%
23.45
20.79
12.79%
Expenses
21.10
22.39
-5.76%
19.53
21.78
-10.33%
15.83
18.94
-16.42%
20.93
19.28
8.56%
EBITDA
1.86
3.13
-40.58%
0.68
1.54
-55.84%
0.73
1.58
-53.80%
2.52
1.51
66.89%
EBIDTM
8.11%
12.25%
3.35%
6.60%
4.42%
7.69%
10.76%
7.26%
Other Income
0.18
0.22
-18.18%
0.44
0.62
-29.03%
0.13
0.03
333.33%
0.39
0.20
95.00%
Interest
0.21
0.30
-30.00%
0.09
0.26
-65.38%
0.16
0.28
-42.86%
0.28
0.32
-12.50%
Depreciation
0.42
0.39
7.69%
0.41
0.39
5.13%
0.39
0.38
2.63%
0.39
0.43
-9.30%
PBT
1.42
2.65
-46.42%
0.61
1.51
-59.60%
0.30
0.94
-68.09%
2.24
0.96
133.33%
Tax
0.00
0.00
0
0.00
0.18
-100.00%
0.00
0.00
0
0.00
0.00
0
PAT
1.42
2.65
-46.42%
0.61
1.34
-54.48%
0.30
0.94
-68.09%
2.24
0.96
133.33%
PATM
6.18%
10.39%
3.04%
5.73%
1.83%
4.57%
9.54%
4.59%
EPS
-0.61
3.25
-
0.52
-0.50
-
1.87
-0.81
-
2.71
-1.51
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
83.19
85.74
82.56
79.49
63.20
91.18
77.25
Net Sales Growth
-7.71%
3.85%
3.86%
25.78%
-30.69%
18.03%
 
Cost Of Goods Sold
47.81
51.02
54.07
56.62
50.60
62.79
47.57
Gross Profit
35.38
34.72
28.48
22.87
12.60
28.40
29.67
GP Margin
42.53%
40.49%
34.50%
28.77%
19.94%
31.15%
38.41%
Total Expenditure
77.39
78.68
81.22
76.42
89.62
105.44
76.73
Power & Fuel Cost
-
2.23
1.88
1.73
3.23
3.99
2.70
% Of Sales
-
2.60%
2.28%
2.18%
5.11%
4.38%
3.50%
Employee Cost
-
14.62
12.45
10.09
16.00
16.85
12.04
% Of Sales
-
17.05%
15.08%
12.69%
25.32%
18.48%
15.59%
Manufacturing Exp.
-
4.38
3.87
3.04
7.85
9.53
5.44
% Of Sales
-
5.11%
4.69%
3.82%
12.42%
10.45%
7.04%
General & Admin Exp.
-
3.58
3.04
2.74
5.42
6.37
4.19
% Of Sales
-
4.18%
3.68%
3.45%
8.58%
6.99%
5.42%
Selling & Distn. Exp.
-
1.57
1.40
0.99
1.68
1.69
1.54
% Of Sales
-
1.83%
1.70%
1.25%
2.66%
1.85%
1.99%
Miscellaneous Exp.
-
1.28
4.50
1.22
4.84
4.22
3.23
% Of Sales
-
1.49%
5.45%
1.53%
7.66%
4.63%
4.18%
EBITDA
5.79
7.06
1.34
3.07
-26.42
-14.26
0.52
EBITDA Margin
6.96%
8.23%
1.62%
3.86%
-41.80%
-15.64%
0.67%
Other Income
1.14
1.17
4.48
1.11
0.21
0.80
0.74
Interest
0.74
0.84
1.03
0.84
2.18
3.10
3.10
Depreciation
1.61
1.59
1.60
1.77
7.03
7.35
7.14
PBT
4.57
5.80
3.19
1.55
-35.42
-23.90
-8.99
Tax
0.00
0.00
0.18
0.03
-7.32
-4.59
10.38
Tax Rate
0.00%
0.00%
5.64%
1.94%
20.88%
19.21%
-115.46%
PAT
4.57
24.58
-9.97
-19.59
-20.90
-11.29
-19.38
PAT before Minority Interest
4.57
24.58
-9.97
-19.59
-31.05
-19.31
-19.38
Minority Interest
0.00
0.00
0.00
0.00
10.15
8.02
0.00
PAT Margin
5.49%
28.67%
-12.08%
-24.64%
-33.07%
-12.38%
-25.09%
PAT Growth
-22.41%
-
-
-
-
-
 
EPS
1.55
8.33
-3.38
-6.64
-7.08
-3.83
-6.57

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
122.66
98.10
65.59
73.95
87.49
79.15
Share Capital
29.46
29.46
26.25
24.70
24.70
24.70
Total Reserves
93.20
68.65
39.34
49.25
62.79
54.45
Non-Current Liabilities
3.70
2.75
1.81
2.62
11.36
19.31
Secured Loans
1.19
0.13
0.00
0.00
9.29
14.44
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.10
0.88
0.93
1.46
2.17
1.54
Current Liabilities
21.81
22.84
23.05
33.02
48.88
63.61
Trade Payables
11.44
13.62
15.44
23.37
28.00
30.95
Other Current Liabilities
3.28
2.37
1.92
2.67
8.80
17.89
Short Term Borrowings
5.90
5.90
5.04
5.66
11.05
13.64
Short Term Provisions
1.19
0.95
0.64
1.32
1.03
1.13
Total Liabilities
148.17
123.69
90.45
109.59
194.56
162.07
Net Block
14.52
13.98
13.67
15.01
110.01
107.56
Gross Block
26.00
25.15
23.27
22.83
142.81
133.42
Accumulated Depreciation
11.48
11.17
9.60
7.83
32.79
25.86
Non Current Assets
110.76
89.82
59.40
81.99
133.37
112.19
Capital Work in Progress
1.19
0.00
0.00
0.00
15.11
0.83
Non Current Investment
92.34
73.55
42.91
64.03
0.06
0.02
Long Term Loans & Adv.
2.57
2.19
2.68
2.79
7.97
3.48
Other Non Current Assets
0.14
0.09
0.13
0.17
0.22
0.31
Current Assets
37.42
33.88
31.05
27.61
61.18
47.36
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
11.02
9.20
9.61
11.30
27.52
23.60
Sundry Debtors
16.11
19.99
16.32
12.75
17.66
13.70
Cash & Bank
7.55
1.25
0.69
1.08
3.81
1.70
Other Current Assets
2.73
1.22
1.86
0.40
12.19
8.35
Short Term Loans & Adv.
2.20
2.21
2.57
2.08
10.64
7.70
Net Current Assets
15.60
11.03
8.00
-5.42
12.30
-16.25
Total Assets
148.18
123.70
90.45
109.60
194.55
159.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
9.29
2.63
-9.80
-14.49
-37.44
4.46
PBT
24.58
-9.79
-19.57
-38.37
-23.90
-8.99
Adjustment
-17.14
14.43
22.64
12.61
11.05
10.29
Changes in Working Capital
1.78
-2.52
-13.08
11.43
-24.33
7.37
Cash after chg. in Working capital
9.22
2.12
-10.00
-14.34
-37.18
8.66
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.07
0.51
0.20
-0.15
-0.26
-4.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2.92
-45.14
0.18
0.49
-24.91
-5.13
Net Fixed Assets
-2.04
-1.88
-0.44
-0.64
-2.53
Net Investments
-0.01
-43.66
-0.01
-0.01
-0.03
Others
-0.87
0.40
0.63
1.14
-22.35
Cash from Financing Activity
0.17
42.43
9.72
11.41
64.07
1.16
Net Cash Inflow / Outflow
6.54
-0.08
0.10
-2.58
1.72
0.49
Opening Cash & Equivalents
0.04
0.13
0.02
2.61
0.88
0.40
Closing Cash & Equivalent
6.59
0.04
0.13
0.02
2.61
0.88

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
41.64
33.30
24.99
29.65
35.07
32.04
ROA
18.08%
-9.31%
-19.59%
-20.41%
-10.83%
-11.95%
ROE
22.27%
-12.18%
-28.08%
-38.46%
-23.18%
-24.48%
ROCE
21.72%
-10.03%
-24.92%
-37.83%
-18.72%
-5.33%
Fixed Asset Turnover
3.35
3.41
3.45
0.76
0.66
0.58
Receivable days
76.86
80.26
66.75
87.83
62.77
64.72
Inventory Days
43.05
41.59
48.02
112.11
102.32
111.53
Payable days
89.64
98.11
125.11
185.27
171.35
237.48
Cash Conversion Cycle
30.27
23.75
-10.34
14.66
-6.26
-61.23
Total Debt/Equity
0.06
0.06
0.08
0.08
0.28
0.40
Interest Cover
30.43
-8.52
-22.16
-16.58
-6.72
-1.90

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


  • Brooks Laboratories incorporates wholly owned subsidiary
    3rd Jul 2026, 09:22 AM

    The incorporation of WOS aligns with the company's strategic objective to expand its business

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.